Blood pressure drug recalled nationwide over possible metal contamination
Multiple pharmaceutical companies issue nationwide recalls for blood pressure medications due to potential metal contamination and foreign tablets.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Recent reporting indicates that multiple blood pressure medications are facing nationwide recalls across the United States. According to coverage from PR Newswire, Medical Daily, Santa Clarita Valley Signal, BioSpace, NBC 5 Chicago, and Fox Business, pharmaceutical companies have initiated voluntary actions regarding specific lots and bottles of widely used cardiovascular drugs. Breckenridge Pharmaceutical, Inc. issued a voluntary nationwide consumer-level recall specifically affecting one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, at the 60 mg dosage strength. At the same time, Advagen has recalled thousands of bottles of metoprolol after reports emerged that foreign tablets or capsules were mixed into the product packaging. These concurrent actions have placed two different beta-blocker medications under intense scrutiny regarding manufacturing quality and safety protocols.
The coverage heavily emphasizes the specific product details and the nature of the manufacturing defects that triggered these safety alerts. Outlets such as Medical Daily and BioSpace detail that the Breckenridge recall was prompted by the potential presence of metal contamination and metal fragments within the 60 mg extended-release propranolol capsules. Meanwhile, reports from NBC 5 Chicago and Fox Business frame the broader issue around nationwide safety alerts for blood pressure drugs, while local sources like the Santa Clarita Valley Signal highlight the alarming discovery of foreign tablets embedded within medication supplies. The media attention directs consumers to immediately check their prescription bottles for the affected lot numbers and medication types, though the available coverage does not yet specify the total number of adverse events reported or the exact geographic distribution of the contaminated lots beyond the nationwide scope.
This string of pharmaceutical recalls arrives amid heightened consumer sensitivity regarding the safety and purity of generic prescription medications distributed across the country. Beta-blockers such as propranolol and metoprolol are standard treatments for hypertension, cardiac arrhythmias, and chronic migraine prevention, meaning that any disruption or safety scare in the supply chain directly affects a vast demographic of patients who rely on these daily doses for blood pressure management. While manufacturing facility inspections and quality control audits are standard procedure following such contamination discoveries, the current news reports do not yet provide background information on the root cause at the manufacturing plants, nor do they name the specific factories responsible for producing the affected lots of medication.
As the situation develops, consumers and medical professionals are advised to monitor further updates from regulatory authorities and the pharmaceutical companies involved. The current coverage does not yet specify a timeline for when the recall process will conclude or whether additional lots, dosages, or drug formulations will be added to the nationwide action. Observers will be watching for official statements regarding how the metal contamination and foreign tablets entered the packaging lines, as well as instructions from health agencies on how patients should safely return or dispose of the affected products without interrupting their necessary medical treatments.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 23h ago.
Quick answers
Which companies issued the recalls?
Breckenridge Pharmaceutical, Inc. and Advagen have issued recalls for their respective blood pressure medications.
What specific drugs are affected by the recalls?
Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, and metoprolol bottles are currently affected.
What prompted the nationwide recalls?
The recalls were triggered by potential metal contamination, metal fragments, and the presence of foreign tablets or capsules found in the products.
Coverage (16)
- Medication used to treat high blood pressure recalled due to potential metal contamination kare11.com · 1d ago
- Medication used to treat blood pressure recalled over possible metal contamination, company says WCVB · 1d ago
- Medication used to treat high blood pressure recalled due to potential metal contamination 10TV · 1d ago
- Breckenridge recalls propranolol over possible metal contamination qz.com · 1d ago
- Medication used to treat blood pressure recalled over possible metal contamination KOAT · 1d ago
- FDA: Blood Pressure Medication Recalled Nationwide Because of ‘Foreign Tablets’ The Healthy @Reader's Digest · 1d ago
- Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination PR Newswire · 1d ago
- Advagen recalls thousands of metoprolol bottles after possible foreign tablets or capsules were found in the product Medical Daily · 1d ago
- Blood pressure medication recalled over ‘foreign tablets’ Santa Clarita Valley Signal · 1d ago
- Check your propranolol bottle: Breckenridge recalls 60 mg capsules over possible metal fragments Medical Daily · 1d ago
- Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination BioSpace · 1d ago
- Blood pressure medication recalled nationwide over possible metal contamination NBC 5 Chicago · 1d ago
- Blood pressure drug recalled nationwide over possible metal contamination Fox Business · 1d ago
- Blood pressure medication recalled nationwide. See affected drug USA Today · 1d ago
- Blood-pressure medication recalled over potential contamination with metal, laceration risk https://www.nxsmediawire.com/ · 1d ago
- This Popular Blood Pressure Medication Has Just Been Recalled Over Possible Metal Contamination Prevention · 1d ago
Topics
Related trends
Popular children’s snack recalled over choking risk, warns FDA
A popular children's snack faces an official recall warning over a potential choking hazard for toddlers.
Bodum USA Recalls 5.9 Million French Press Coffee Makers with Replaceable Glass Carafes Due to Risk of Serious Burn Injury
Bodum USA issues a recall for nearly six million French press coffee makers featuring replaceable glass carafes.
Toyota recalls over 105,000 vehicles. See the affected model
Toyota initiates a major vehicle recall affecting over 105,000 units in the United States due to an identified fire risk.
Mercedes-Benz Recalls 30,000-Plus S-Class Sedans for Brake Issue
Mercedes-Benz has recalled over 30,000 S-Class luxury sedans due to a dangerous front brake hose issue.
More than 720K BMW vehicles recalled over fire threat, regulators say
BMW recalls over 720,000 vehicles across multiple model lines after regulators identify a water pump fire risk that prompts an urgent park-outside advisory.
Consumer Alert: Urgent Park Outside Recall Issued for Nearly 721K BMW Vehicles
Drivers of nearly 721,000 BMW vehicles are urged to park outside due to a fire risk.